Anika Therapeutics, Inc. (ANIK) key performance indicators and operating metrics (8 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | 4.3M | FY2026-Q1 |
| Adjusted Diluted Earnings per Share from Continuing Operations | 0.27 USD_per_share | FY2026-Q1 |
| Commercial Channel Revenue Growth Rate (Year over Year, Expected) | 12.00 percent | FY2026-Q1 |
| Commercial Channel Revenue Guidance | 12.6M | FY2026-Q1 |
| Original Equipment Manufacturer Channel Revenue Growth Rate (Expected) | 14.00 percent | FY2026-Q1 |
| Original Equipment Manufacturer Channel Revenue Guidance | 17M | FY2026-Q1 |
| Regenerative Solutions Revenue Growth Rate | 20.00 percent | FY2026-Q1 |
| International Osteoarthritis Pain Management Revenue Growth Rate (Year over Year) | 21.00 percent | FY2025-Q3 |
Back to ANIK overview · ANIK earnings · ANIK holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.